Search for Stocks /

Titan Biotech Ltd Q3 FY26: 47.6% Sales Jump, 94.3% PAT Surge — But At 42.7 P/E, Is The Market Already High On Peptones?


1. At a Glance – This Biotech Just Dropped a 94% Profit Mic 🎤

Market Cap: ₹1,161 Cr.
Current Price: ₹1,405
3-Month Return: 34.1%
1-Year Return: 194%
ROCE: 16.9%
ROE: 15.0%
P/E: 42.7
Book Value: ₹201
Debt to Equity: 0.05

Q3 FY26 numbers came in like a lab experiment that actually worked. Revenue rose 47.6% YoY to ₹56.51 Cr. Net profit exploded 94.3% YoY to ₹8.53 Cr. EPS jumped to ₹10.32 from ₹5.31 last year.

This is not “mild improvement.” This is “who switched on the fermentation reactor?” kind of improvement.

And the market? It noticed. The stock is flirting with its 52-week high of ₹1,435.

But here’s the real question:
Are we looking at a long-term biological compounding machine… or just one very strong quarter wearing a lab coat?

Let’s open the microscope.


2. Introduction – From Peptones to Profits

Titan Biotech is not making COVID vaccines.
It’s not editing genes.
It’s not curing cancer.

It’s doing something far more boring — and often more profitable.

It manufactures biological ingredients used in pharmaceuticals, nutraceuticals, fermentation, agriculture, microbiology culture media, probiotics, animal feed… basically anything that grows, cultures, or ferments.

Think of them as the supplier to the suppliers.

And boring businesses often make very serious money.

Founded in 1992, the company is ISO-certified, cGMP compliant, FSSC 22000 certified, and a member of export councils like Pharmexcil, Capexil, and Chemexcil. That’s a lot of compliance. Which in biotech is like oxygen — no oxygen, no survival.

The company operates a 5,150 TPA facility in Rajasthan and earns 69% of revenue domestically and 31% from exports (FY23).

Revenue mix (FY23):

  • Peptones: 54%
  • Chemicals: 24%
  • Culture: 20%
  • Others: 2%

Translation?
More than half the revenue depends on peptones — a fermentation ingredient.

So the big question becomes:

Is Titan diversified… or just well-dressed concentration risk?

Let’s decode.


3. Business Model – WTF Do They Even Do?

Imagine you run a pharma company. Or a probiotic brand. Or an animal feed plant.

You need biological raw materials — peptones, yeast extracts, collagen, plant growth regulators, bio-fertilizers, culture media.

That’s where Titan walks in.

Their product categories include:

  • Food ingredients
  • Collagen & proteins
  • Pharmaceuticals &
Read Full 16 Point breakdown. Continue reading →
Members get full access to every article.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →